Sundhedsvæsenet enig om nyt blodtryksmål for risikogrupper

1. juni 2026

Rapporteret af AI

Kun hver femte person med forhøjet blodtryk får tilstrækkelig behandling i Sverige. Sundhedsudbydere er nu blevet enige om et nyt behandlingsforløb for at forbedre opsporing og behandling.

Sundhedsudbydere er blevet enige om et nyt behandlingsforløb for forhøjet blodtryk. Den diagnostiske grænseværdi forbliver på 140/90 mmHg. For personer i behandling bør målværdien for de fleste være 130/80 mmHg.

Forhøjet blodtryk er den vigtigste globale risikofaktor for for tidlig død. Det øger risikoen for slagtilfælde, hjertesvigt og hjerteanfald. Sunde livsstilsvaner og medicin danner grundlaget for behandlingen.

Omkring halvdelen af befolkningen i Sverige modtager en hypertensiondiagnose før 65-årsalderen. Sundhedstjenesterne vil nu blive bedre til at identificere personer i risikozonen, ifølge rapporter fra Dagens Medicin.

Relaterede artikler

Pediatrician assessing overweight children in clinic, highlighting study-recommended early treatment to prevent adult risks like diabetes and hypertension.

Study recommends treatment for all children with obesity

23. marts 2026 Rapporteret af AI Billede genereret af AI

A new Karolinska Institutet study finds that children with moderate obesity face higher risks of type 2 diabetes, high blood pressure, and lipid disorders in adulthood, even without apparent risk markers. Researchers urge treatment for all such children.

ACC and AHA release updated cholesterol management guidelines

The American College of Cardiology and American Heart Association have issued new guidelines on cholesterol screening and management, urging earlier testing and personalized risk assessments. The recommendations, presented on March 28 in New Orleans, emphasize lowering LDL cholesterol and incorporating genetic factors like lipoprotein(a). A new risk calculator aims to predict heart disease over longer periods.

Study reveals excess cortisol in 27% of resistant hypertension patients

30. marts 2026 Rapporteret af AI

A large U.S. study has found that 27 percent of patients with resistant hypertension have hypercortisolism, an excess of the stress hormone cortisol. The MOMENTUM study, involving 1,086 participants across 50 centers, showed this condition is far more common than previously thought in those whose blood pressure remains high despite multiple medications. The discovery suggests screening for elevated cortisol could help explain treatment failures.

Sundhed

tirsdag d. 26. maj 2026, 04.36

Sundhedsvæsenet enig om nyt blodtryksmål for risikogrupper

Relaterede artikler

Study recommends treatment for all children with obesity

ACC and AHA release updated cholesterol management guidelines

Study reveals excess cortisol in 27% of resistant hypertension patients

Irregular bedtimes in midlife linked to higher heart risks

Brief bursts of vigorous activity tied to lower risks across eight major disease groups, study finds

Majority in Region Uppsala proposes 592 million extra for healthcare

Beetroot juice linked to lower blood pressure in older adults after two weeks, study finds

Region Dalarna banned from high doctor overtime

Beans and soy linked to lower hypertension risk

Region Uppsala first with pilot for self-hearing test

Baduanjin, an ancient Chinese mind-body exercise, lowered blood pressure in a randomized trial

Diabetes detection needs better tools to catch early cases

Hitting urate targets with gout-lowering therapy is linked to lower cardiovascular risk in large UK study

Single-dose zilebesiran as add-on therapy lowers systolic blood pressure in KARDIA-2 trial

Public Health Agency issues new advice for better youth sleep

Dette websted bruger cookies